Company / Capital Returned to Shareholders
Zoetis Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$248.0M
FY2025
5-year range
$248.0M / $1.9B
FY2021-FY2025
Trend
-86.7%
vs FY2024
Sector context
#15 of 52
Health Care
What the data says
At $248M, Zoetis's capital returned to shareholders ranks #15 of 52 in the Health Care sector. Capital Returned to Shareholders has fluctuated over the past 10 years, ranging from $146M in FY2016 to $1.9B in FY2024.
Based on SEC 10-K filings.
$248M in FY2025 with a 5-year CAGR of -23.4%.
Declined from $1.2B to $248M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -26.7%
- 5-Year CAGR
- -23.4%
- 10-Year CAGR
- -
Sector benchmark
#15 of 52 in Health CareTop 29% of 52This company $248.0M Sector average $1.3B
▼
-81.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -23.4%, indicating a declining trend.
- In FY2025, capital returned to shareholders decreased 86.7% year-over-year.
- Ranks #15 out of 52 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2024.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $248.0M | -86.7% |
| FY2024 | $1.9B | +52.7% |
| FY2023 | $1.2B | +93.2% |
| FY2022 | $630.0M | -33.0% |
| FY2021 | $940.0M | -0.1% |
| FY2020 | $941.0M | +50.3% |
| FY2019 | $626.0M | -10.3% |
| FY2018 | $698.0M | +88.1% |
| FY2017 | $371.0M | +154.1% |
| FY2016 | $146.0M | +49.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026